Ask Warren

Yungjin Pharm

003520 · KOSPI · ₩003520 · 영진약품

₩931 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩254B₩252B₩235B₩218B₩196B
Cost of sales₩177B₩172B₩163B₩154B₩138B
Gross profit₩77B₩80B₩72B₩65B₩58B
Operating income₩3.4B₩8.7B₩3.1B−₩7.4B−₩14B
Net income−₩228M₩1.2B−₩3.9B−₩22B−₩12B
Net income to shareholders−₩228M₩1.2B−₩3.9B−₩22B−₩12B

Balance sheet

20252024202320222021
Total assets₩262B₩234B₩227B₩203B₩194B
Current assets₩146B₩124B₩127B₩102B₩90B
Cash and equivalents₩28B₩3.4B₩7.2B₩682M₩465M
Total liabilities₩171B₩144B₩137B₩113B₩89B
Current liabilities₩99B₩115B₩75B₩50B₩48B
Borrowings₩71B₩64B₩65B₩39B₩11B
Total equity₩91B₩90B₩90B₩90B₩105B
Shareholders' equity₩91B₩90B₩90B₩90B₩105B

Cash flow

20252024202320222021
Cash from operations₩12B₩22B−₩10B−₩12B₩8.4B
Capital spending₩11B₩21B₩10B₩13B₩11B
Free cash flow₩546M₩446M−₩20B−₩24B−₩2.7B

Consolidated where available. Amounts in won.

Also known as: Yungjin Pharm / 영진약품 / 003520 / KRX:003520

Source: KRX statistical information